Improvement in Designing, Formulation, and Development through QBD-Based SOPs: A Review

The landscape of pharmaceutical development has transitioned from conventional trial-and-error methods to more structured, science-driven, and risk-based approaches. Among these, Quality by Design (QbD) has established itself as a pivotal framework in optimizing formulation and manufacturing processes. Integrating QbD principles into Standard Operating Procedures (SOPs) fosters a systematic and data-centric pathway for product development, ensuring enhanced reproducibility and regulatory compliance. By embedding quality at the earliest stages, QbD-based SOPs contribute to improved formulation strategies, reduced variability, and better alignment with global regulatory expectations. This review highlights the critical role of QbD-integrated SOPs in strengthening pharmaceutical design, advancing formulation robustness, and streamlining development activities. Key elements such as Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), Critical Process Parameters (CPPs), and the application of risk management methodologies are explored. In addition, practical insights through case studies and specific applications within the Indian pharmaceutical sector are discussed to illustrate the real-world impact of QbD-based SOPs. It highlights key QbD elements—Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), Critical Material Attributes (CMAs), and Critical Process Parameters (CPPs)—and explores their incorporation into SOPs to achieve regulatory compliance and product quality assurance.